Back to Trades
Total Value
$561.2K
Net $225.4K sold
Filing Date
Jun 22, 2026
1 transaction
Sales
$225.4K
1 transaction
Trade Summary
On Jun 17, 2026, Kaye Jack, Director, sold $561.2K of uniQure N.V. (QURE) across 1 transaction. The filing covers Ordinary Shares and reflects net selling of $225.4K. Reported prices ranged from $31.71 to $42.57. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- uniQure N.V.
- Ticker Symbol
- QURE
- CIK
- 0001590560
Insider Information
- Name
- Kaye Jack
- Role
- Director
Filing Details
- Filing Date
- Jun 22, 2026
- Transaction Date
- Jun 17, 2026
- Accession Number
- 0000904454-26-000368
- Form Type
- 4
- Net Trading Amount
- -$225.4K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Ordinary Shares | 5,295 | $31.71 | Exercise | $167.9K |
| Jun 17, 2026 | Ordinary Shares | 5,295 | $42.57 | Sale | $225.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | QURE derivative | 5,295 | $31.71 | Exercise | $167.9K |
Want live alerts when Kaye Jack trades again?
Download Insider Trades to track QURE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- (F2)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
- (F3)The Stock Option vested in full on January 25, 2020.